Company Website

Contact Information:

Anne Steffen
(507) 479-0327
Anne.Steffen@astrazeneca.com

Denise Hodgen
(612) 991-7965
Denise.hodgen@astrazeneca.com

Nate Hagen
(507) 381-0700
Nate.hagen@astrazeneca.com

Ashley Link
(612) 770-3105
Ashley.link@astrazeneca.com

Tom Trudel 
(612) 210-8155
Tom.Trudel@astrazeneca.com

Virtual Exhibit Hall Home

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory & Immunology.

For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.

Additional Information:

TAGRISSO® (osimertinib) US Prescribing Information  
IMFINZI® (durvalumab) US Prescribing Information  
CALQUENCE® (acalabrutinib) US Prescribing Information
LYNPARZA® (olaparib) US Prescribing Information
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Full US Prescribing Information. See Boxed WARNINGS